Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H5Cl2NO |
| Molecular Weight | 214.048 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C2N=CC=CC2=C(Cl)C=C1Cl
InChI
InChIKey=WDFKMLRRRCGAKS-UHFFFAOYSA-N
InChI=1S/C9H5Cl2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
| Molecular Formula | C9H5Cl2NO |
| Molecular Weight | 214.048 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chloroxine, a dichloroquinolinol, was first prepared by A. Hebebrand in 1888. It is an antibacterial drug that has been incorporated into shampoos to treat dandruff and seborrheic dermatitis. It has also been used internally as an antidiarrheal and in the lab as an analytical reagent. The drug was withdrawn from the market in the US by unknown reason.
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
0.713 μg/g EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
60.72 μg × min/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
48.72 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/16910862/ |
2 μL single, oral dose: 2 μL route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROXINE plasma | Oryctolagus cuniculus population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction. | 2013-03-28 |
|
| N,N-Dicyclo-hexyl-2-(5,7-dichloro-8-quinol-yloxy)acetamide. | 2009-10-07 |
|
| 5,7-Dichloro-quinolin-8-ol. | 2009-04-25 |
|
| Synthesis of nano-pore samarium (III)-imprinted polymer for preconcentrative separation of samarium ions from other lanthanide ions via solid phase extraction. | 2008-08-08 |
|
| Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. | 2007-11-01 |
|
| Investigation of the role of chelating ligand in the synthesis of ion-imprinted polymeric resins on the selective enrichment of uranium(VI). | 2007-03-28 |
|
| Ion imprinted polymer particles for separation of yttrium from selected lanthanides. | 2006-06 |
|
| The evaluation of liposome-water partitioning of 8-hydroxyquinolines and their copper complexes. | 2006-03-15 |
|
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005-06 |
|
| Solid phase extraction preconcentration of cobalt and nickel with 5,7-dichloroquinone-8-ol embedded styrene-ethylene glycol dimethacrylate polymer particles and determination by flame atomic absorption spectrometry (FAAS). | 2005-04-15 |
|
| Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. | 2005 |
|
| Selective recognition of neodymium (III) using ion imprinted polymer particles. | 2004-09-24 |
|
| A monooxygenase catalyzes sequential dechlorinations of 2,4,6-trichlorophenol by oxidative and hydrolytic reactions. | 2004-02-20 |
|
| Solid phase extractive preconcentration of thorium onto 5,7-dichloroquinoline-8-ol modified benzophenone. | 2002-10-16 |
|
| Structure-activity studies in E. coli strains on ochratoxin A (OTA) and its analogues implicate a genotoxic free radical and a cytotoxic thiol derivative as reactive metabolites. | 1994-05-01 |
|
| Genotoxicity of ochratoxin A and structurally related compounds in Escherichia coli strains: studies on their mode of action. | 1991 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.drugs.com/pro/capitrol.html
Curator's Comment: Chloroxine is used as a topical shampoo containing 2% (w/w) chloroxine.
Apply onto the wet scalp, leave on for approximately three minutes, then rinse.
Route of Administration:
Topical
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:51:05 GMT 2025
by
admin
on
Mon Mar 31 17:51:05 GMT 2025
|
| Record UNII |
2I8BD50I8B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29708
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
212-258-3
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
C004357
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200596
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
2722
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
2I8BD50I8B
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
3904
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
Chloroxine
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
59477
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
SUB13339MIG
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
DB01243
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
100000091041
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
611
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
773-76-2
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
C47446
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
DTXSID5022801
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | |||
|
20875
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | RxNorm | ||
|
m3451
Created by
admin on Mon Mar 31 17:51:05 GMT 2025 , Edited by admin on Mon Mar 31 17:51:05 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |